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HeteromerWe have studied the role of loop 9 in the function of neuronal nicotinic receptors. By systematically mutating
the residues in the loop we have determined that the most important amino acids determining the coupling
of binding to gating are the ones closer to the transmembrane region. Single mutations at location E173 in
homomeric α7 receptors destroyed their function by completely abolishing the current while preserving the
expression at the membrane. In contrast, heteromeric receptor α3β4 with the same mutations retained
some function. We conclude that loop 9 has a different role in the function of homomeric and heteromeric
receptors.icotinic acetylcholine receptor;
ll rights reserved.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Neuronal nicotinic acetylcholine receptors (nAChR) are ligand-
gated ion channels composed of ﬁve homologous or identical subunits
[5,19]. Structural information of nAChR have been obtained at atomic
resolution from Torpedo receptors [26], homologous molluscan ACh-
binding proteins [3], and from the extracellular domain of mouse α1
subunits [7]. In all cases the extracellular domain of each subunit has a
similar structural organization containing an N-terminal α-helix, a
core of 10 β-strands, and several loops linking the different elements.
In Torpedo receptors, the ﬁrst ones from which we have structural
data on the transmembrane regions, loops 2, 7 and 9 are part of the
interface with the transmembrane domain and have been implicated
in coupling ligand binding to channel opening [25]. In particular, it has
been hypothesized that agonist binding induces the movement of
loop 9 (linking sheets β8 and β9) [21]. In addition, the X-ray structure
of two complete prokaryotic ligand-gated ion channel analogs has
shown similar features [2,14].
We had previously studied in detail the interactions of loops 2 and
7 with the M2–M3 linker that are involved in the gating of the α7
nicotinic receptor [1,23]. Loops 2, 3 and the M2–M3 linker form the
interface between the extracellular and transmembrane receptor
domains. In contrast with loops 2 and 7, loop 9 (L9) does not seem to
be so close to the transmembrane domains in the structural models,
and its role has not been studied exhaustively. However, its large size
and presumably large ﬂexibility make it a very good candidate forinteractions not only with the transmembrane domains, but also with
extracellular regions of neighboring subunits.
On the other hand, studies done in muscle nAChRs have suggested
that only in α subunits residues of loops 2 and 7 contribute appreciably
to coupling binding to gating, whereas residues at equivalent positions
of non-α-subunits show negligible coupling [18]. Thus, we decided to
undertake a systematic study of the role of the residues in L9 in the
gating of both the homomeric α7 and the heteromeric α3β4 receptors
where the role of residues in loop 9 could be studied in α and non-α
subunits.
2. Materials and methods
2.1. Generation of mutants
The bovine α7 cDNA [11] was cloned in a derivative of the pSP64T
vector [16] containing part of the pBluescript polylinker. Heteromeric
nAChRs made of human α3 and rat β4 subunits were also used.
Mutants were generated by using single-stranded oligonucleotides
with the desired sequences and proper single-strand ends which
could be easily ligated to the ends generated by restriction enzymes
either present in the original sequences or introduced by PCR as silent
mutations. Modiﬁed α3 [20] or β4 [24] subunits able to bind α-Bgt
(designatedα3* and β4* henceforth) were always used in combination
with the corresponding non-modiﬁed subunit where the mutation was
introduced.
2.2. Oocyte expression
Capped mRNA was synthesized in vitro using SP6 RNA polymerase,
the mMESSAGE-mMACHINE kit (Applied Biosystems, Madrid, Spain)
and the pSP64T derivative mentioned above. Defoliculated Xenopus
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water. All experiments were performed within 2–3 days after cRNA
injection. mRNA of wild-type receptors was injected into oocytes from
the same frog every time a mutant was tested. Consequently, mutant
expression was expressed as a percentage of wild-type receptor
expression observed in the same experiment.
2.3. [125I]-α-bungarotoxin binding assays
Speciﬁc surface expression of [125I]-α-bungarotoxin (α-Bgt)
(PerkinElmer España, Madrid, Spain) binding sites in α7 receptors
was tested with 10 nM [125I]-α-Bgt as described [10].
Brieﬂy, 40 oocytes located in 24-well plates were pre-incubated for
15 min with Barth's buffer (in mM: 84 NaCl, 1 KCl, 2.4 HCO3Na, 0.82
MgSO4, 0.33 Ca(NO3)2, 0.41 CaCl2, 7.5 Tris–Cl pH 7.4) containing 5% of
fetal calf serum and further incubated in the samemediumwith 10 nM
[125I]-α-Bgt for 2 h at 18 °C in a ﬁnal volume of 250 μl. At the end of the
incubation, unbound [125I]-α-Bgt was removed, oocytes were passed to
6-well plates, washed ﬁve times with 4 ml Barth's buffer and bound
radioactivity was counted.
Binding of [125I]-α-Bgt to heteromeric α3β4 receptors was
performed in the same way, except for the use of a ﬁnal concentration
of 67 nM [125I]-α-Bgt. In this case mutant α3 [20] or β4 [24] subunits
able to bind α-Bgt were used in combination with the corresponding
non-binding subunit.
Given the location of themutations, it is unlikely that they can affect
α-Bgt binding properties. Nevertheless, some low-expressing mutants
were analyzed with higher toxin concentrations in order to discount
potential decreases in toxin afﬁnity.
All binding experiments with mutant receptors (and the
corresponding WT) were repeated with two or three different donors
in successive weeks and the ratio of α-Bgt binding for mutant to WT
was expressed as mean±s.e.m.
2.4. Electrophysiological recordings
Electrophysiological recordings were carried out as previously
described [10]. Extracellular solution contained (in mM): NaCl 82.5,
KCl 2.5, BaCl2 2.5, MgCl2 1 and HEPES 5 (pH 7.4). This solution, by
substituting calcium by barium, diminishes the activation of calcium-
activated chloride currents. The velocity of application of agonists was
18–22 ml min−1. Functional expression of each construct was estimat-
ed as the peak ionic current evoked by 4 s application of 1 or 3 mMACh
at −80 mV and no correction for desensitization was made. All
experiments were performed at room temperature (22 °C). Data
analysis was performed with Prism 4.0 (GraphPad Software Inc., San
Diego, CA, USA). Dose–response curves were ﬁtted using a nonlinear
least squares algorithm to the Hill equation, I/Imax=1/(1+(EC50/C)
h). Data are expressed as mean±s.e.m. Statistical signiﬁcance was
calculated by one-way ANOVA test and, when a signiﬁcant F value was
obtained, by Bonferroni's multiple comparison test. The null hypothesis
was rejected when pb0.05.
As with the binding experiments, all electrophysiological recordings
of the currents of the mutant receptors (and the corresponding WT)
were repeated with two or three different donors in successive weeks.
Each week at least seven cells expressingmutant and the same number
of cells expressing WT were recorded. The ratio of peak currents for
mutant to WT was expressed as mean±s.e.m.
3. Results
3.1. Alanine scanning mutagenesis of loop 9
Fig. 1 shows, at increasing level of detail, part of a structural
homology model of the bovineα7 subunit depicting in color the aminoacids of L9 explored in the present study. We started with an alanine
scanning mutagenesis study of all these residues.
Plasma membrane expression of mutant nAChRs was monitored
by measuring α-Bgt binding sites at the external surface of oocytes,
and the functional state of these receptors was tested by recording the
ionic currents evoked by a pulse of ACh 1 mM. As an internal control in
all experiments, all current and binding data were compared to wild-
type receptors, and expressed as a fraction of the corresponding
values obtained inWT α7 nAChRs. The results are shown in Fig. 2. We
also calculated the value of C/B to compare the functionality of all
mutants.
As seen in Fig. 2, most of the mutants had a signiﬁcant reduction in
expression, most notably, D164A, Y168A and N171A that had an
expression less than 30% of the control value. On the other hand the
value of the currents for these mutants was also reduced even in a
large proportion, 21%, 12% and 20% respectively, thus giving C/B
values between 0.5 and 0.8 indicating that those mutants had lost
some of their ability to function normally.
In contrast, for mutant M160A, although there was a decrease in
expression to 61±5% of WT, the decrease in current was to only 70±
20% ofWT, thus resulting in an insigniﬁcant increase in function (114±
23%). This effect was most pronounced in mutant I169A where a
decrease to 43±4% in binding was accompanied by only a decrease to
62±6% in the currents, thus giving an increase in function to 145±9%
of control. In a different way, mutant G167A also showed a small
increase in function similar to M160A, but in this case without a
signiﬁcant reduction in expression.
Residues close to the end of L9 turned out to be essential for the
function of the receptor; this is shown inmutant G172A that with only
a small reduction in expression, 72±2% of WT, had a dramatic
decrease in current: only 4±4% of control. The next residue in the
sequence, E173 when mutated to alanine gave a receptor with a
moderate expression, 47±14% ofWT, but with undetectable currents.
Interestingly, the alanine mutation in ﬁrst residue after L9, the highly
conserved W174 produced receptors that were not expressed in the
membrane (data not shown). In the rest of the study we concentrated
in the last two positions in L9 to further investigate its role in the
function of the receptor.
Fig. 2B shows a summary of these results in pictorial form by
applying a linear color code scale on the current–binding ratio (C/B)
to the side chains of the residues of L9.
3.2. Role of the end of L9 on the gating of the homomeric receptor α7
After identifying that alaninemutants at the end of L9 strongly affect
the function of the receptors, and considering that alanine residues have
a hydrophobic side chain, we also wanted to study the effect of other
mutations with amino acids of different characteristics, i.e. with polar
(Ser) or charged side chains of different sign (Asp, and Lys). Mutant
G172S gave, consistently, values of expression close to the control and
currents about ten times smaller but still measurable so we used this
mutant to pursue the study. The resultingpharmacology of thismutated
receptor can be seen in Fig. 3.
The average values for ACh concentration–response curves
parameters (EC50, nH) were for α7 (47±3 μM, 1.87±0.09) and for
G172S (147±4 μM, 1.49±0.04), whereas for DMPP were: α7 (10±
1 μM, 3.03±0.15) and G172S (30±4 μM, 1.97±0.30), n=4 in all
cases. In α7 DMPP gave maximal currents very close to those elicited
by ACh, their ratio being 0.97±0.01 whereas in G172S this ratio was
only 0.66±0.04 (data not shown). Thus G172S has a concentration–
response curve shifted to the right by a factor of 3 both for ACh and
DMPP, and with maximal currents that are approximately ten times
smaller.
The kinetics of the currents was also affected by the mutation. At
saturating concentrations, the rising time from 10% to 90% of the peak
was 21±4 ms (n=6) forα7 and 13±1 (n=10)ms for G172S, and the
Fig. 1. Location of the amino acids in L9 examined in this study. Data are from the bovine α7 subunit homology model based on the electron microscopic studies of Unwin [26] (PDB
code: 2bg9). A. Overview of the structure of a single subunit where L9 appears in color. B. Zoom of the region selected in A showing in color the side chains of residues in L9.
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for G172S. Thus both processes were approximately two times faster in
the mutant.
When a charge is introduced at position G172 the receptor is still
expressed in the membrane, however the current is strongly reduced
in the case of the negatively chargedmutant G172D, and undetectable
in the case of the positively charged one, mutant G172K, that
abolishes the current completely, Fig. 4.
In contrast, mutations in the next position, E173, produced
receptors with a slight reduction in the expression but complete
elimination of the current in all cases, regardless if the mutation
neutralizes, reverses or preserves the charge, as in mutations E173Q,
E173K and E173D respectively, Fig. 4. No current was detected eitherFig. 2. Current, binding and current/binding ratio for alanine mutants in α7 receptors. A
(diamonds) for all residues of L9mutated to alanine. All data have been normalized to the cor
colored in a scale representing the effect on current/binding ratio (C/B) when the residuewhen the concentration of ACh applied was increased from 1 mM to
10 mM.
3.3. Role of the end of L9 on the gating of the heteromeric receptor α3β4
The previously observed reduction in C/B suggests that residues
G172 and E173 play an important role in the gating of the homomeric
α7 receptor. We wondered whether the same happened in hetero-
mers and if so, whether a difference would be observed depending on
which subunit, α or β, would carry the mutations. The results of these
experiments are shown in Fig. 4 for the slowly-desensitizing receptor
α3β4. Contrarily to what happened with mutations in α7 the
corresponding mutations in α3 had a smaller reduction in C/B in. Normalized values of current (squares), binding (circles) and current/binding ratio
responding values obtained in theWTα7 receptor. B. Detail of residues in L9 labeled and
is mutated to alanine.
Fig. 3. Concentration–response curves forWT andG127S.NormalizedACh concentration–
current curves for two representative cells expressing α7 and G127S. Lines through data
points areﬁts to theHill equation. The datawere obtained from the current records shown
beside each curve. Note the 10 fold difference in the current scale.
Fig. 5. Normalized ACh concentration–response curves of heteromeric nAChRs. Shown
are wild-type α3β4 and its mutant α3E175Aβ4E175A, α3*β4 and its mutant
α3*β4E175A, andα3β4* and its mutantα3E175Aβ4*. Lines are ﬁts to the Hill equation.
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mutants that produced receptors with small but measurable currents.
This contrast is even more striking for the mutants in β4 because the
mutation had either no effect at all in C/B (mutant G174A), or only a
relatively small effect (mutants at position E175).
When both subunits, α3 and β4, were mutated simultaneously at
location G174, the reduction of the maximum current was consis-
tently larger than when only one subunit was mutated, but still
smaller than the observed in homomeric α7 receptors. Finally, when
the mutations were simultaneously introduced at location E175, they
did not produced a further decrease of the current as compared with
the one produced by the single mutation of α3 subunit, compare stars
and squares in Fig. 4. Therefore, even in the case of receptorsFig. 4. Current, binding and current/binding ratio for mutants at the end of L9.
Normalized values of current (squares, stars), binding (circles) and current/binding
ratio (diamonds) for mutants of the last two residues of L9 in α7 and in subunits α3 or
β4 of α3β4 receptors. Stars refer to current values obtained in heteromeric α3β4
receptors whose ﬁve subunits have been mutated. In this case no α-Bgt binding could
be determined. All data have been normalized to the values obtained in the WT α7 or
α3β4 receptors, or the corresponding modiﬁed receptors α3β4* and α3*β4.composed of ﬁve mutated subunits, the effects of mutating G174 and
E175 were less pronounced in α3β4 heteromeric receptors.
The possibility that mutations of E175 in either α3 or β4 could be
affecting the binding of ACh was investigated by analyzing concen-
tration–response curves like the ones shown in Fig. 5. The modiﬁca-
tions introduced into α3 or β4 subunits to make them able to bind α-
Bgt produced by themselves clear and opposite effects on the EC50 for
ACh. However, when mutations at location E175 were introduced,
consistent results were observed in both receptors, i.e. a shift in the
curve towards higher concentrations. The average values of the ﬁtted
parameters for EC50, and Hill coefﬁcients are given in Table 1. The
mutations produced statistically signiﬁcant differences in EC50
(pb0.01), but not in the Hill coefﬁcient. On the other hand, the
mutations did not produce a signiﬁcant change in the kinetics of the
currents (data not shown).
The magnitude of the shift in the concentration–response curves
produced by mutations in α3 or β4 subunits is small, approximately a
factor of three as it was observed previously inα7 receptors. The small
magnitude and direction of this effect is predicted as a consequence of
the decrease in gating produced by themutation.Whenmutations are
present in both, α3 and β4 subunits, within the same receptor, the
change in EC50 is larger, approximately a factor of ﬁve, however, in
this case we cannot assess whether this could be a consequence of
decreased gating because we do not have expression data for these
double mutant receptors.
4. Discussion
In this report we have investigated the role of L9 (also referred to
as loop F) in the function of homomeric α7 and heteromeric α3β4
neuronal nAChRs. The systematic mutation of all residues of L9 to
alanine reveals that the end of L9 is especially important in the
function of α7 receptors, as single mutations at the last residue in L9,Table 1
Average values of ﬁtted parameters (EC50, and Hill coefﬁcient) for concentration–
response curves of ACh on heteromeric receptors.
Receptor EC50 (μM) nHill N
α3β4 61±10 2.4±0.4 4
α3*β4 18±3 1.7±0.3 6
α3*β4E175A 63±7 1.4±0.1 6
α3β4* 259±13 3.2±0.4 6
α3E175Aβ4* 559±22 2.9±0.1 5
α3E175Aβ4E175A 321±26 2.9±0.6 4
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affecting its expression in the membrane (Figs. 1 and 2). Interestingly,
even the charge conserving mutation E173D formed non-functional
receptors. This region of L9 sits at the interface between subunits so
that it may interact with loops 5 and 10 that contribute to the ligand-
binding site of the opposite subunit [26].
Mutations at the location previous to E173 in L9 (G172) produced
receptors with small but measurable currents that allowed us to
investigate the role of this part of L9 in coupling of binding to gating.
Besides having a C/B about ten times smaller, the currents of mutant
G172S were also about two fold faster both in the rising and decaying
phase (Fig. 3). Both effects could contribute to the observed shift in
the ACh concentration–response in the mutant without any change in
the binding properties of the receptor [4]. On the other hand the
mutation seemed to change the agonist speciﬁcity of the receptor
because the ratio of peak currents for ACh and DMPP changed from 1
in WT to 0.6 in the mutant.
The special role of the conserved glutamate in L9 inmodulating the
activation of nAChRs has also been studied previously in homomeric
non-desensitizing chick L247T α7 receptors by the substituted-
cysteine accessibility method, concluding that receptor activation
includes subunit rotation and/or intrasubunit conformational
changes that move the corresponding residue E172 to a position
away from the vestibule of the receptor [21]. In these modiﬁed
receptors, the mutation E172C produced a decrease of the maximal
current of 3.8-fold but a two orders of magnitude increase in the EC50
for ACh. We have ruled out the occurrence of a similar shift in EC50 in
our mutated bovine α7 receptors because no current was detected
when pulses of 10 mM ACh were applied (a concentration 200-fold
greater than the EC50 for WT bovine α7 receptors). Thus, E173 seems
to have an important role in the gating of homomeric WT bovine α7
receptors and not so much in modiﬁed receptors like mutant L247T
α7 that already have an important alteration in their gating behavior.
The dramatic inﬂuence of E173 on the gating of α7 may be due to
the homomeric nature of this receptor in contrast to the more modest
effect on heteromeric receptors, Fig. 4. By using heteromeric α3β4
receptors, and assuming a 2:3 stoichiometry [13], we were able to
analyze the effect of mutating only two (α3) or three (β4) subunits at
a time. (Although there is no direct evidence of a ﬁxed subunit
stoichiometry for α3β4 receptors expressed in oocytes, this is
suggested by monophasic ACh concentration–response curves). In
this case the mutant receptor was still functional although with a
reduction in its ability to couple binding to gating, as measured by the
C/B ratio, Fig. 4. In order to measure the number of heteromeric
receptors in the membrane we used modiﬁed α3 or β4 subunits in
which the sequence of the α1 subunit C-loop is inserted [20,24]. Both
modiﬁcations probably altered the binding properties of the receptors
because the ACh concentration–response curves were shifted in
opposite directions by three fold, Fig. 5, without a change in the
magnitude of the current. Nevertheless, the mutation in the
corresponding glutamate in α3 or β4 subunits shifted the EC50 values
by a factor close to 3, but in this case with a corresponding reduction
in C/B. In these slowly-desensitizing receptors this shift in EC50 could
be explained just by the reduction in C/B, [4]. Glutamate at the end of
L9 has been shown to be a determinant of agonist afﬁnity in muscle
nAChRs [6,22], however the effect of E173 on ACh binding on neuronal
nAChRs does not seem to be as important.
L9 has also been involved in the calcium binding site that regulates
the potentiation of the receptor. Mutations in E172 in the α7-V201-
5HT3 chimera have been shown to abolish calcium effects on ionic
current amplitudes and agonist afﬁnity [9]. Based on molecular
models of chick α7 receptors, the same glutamate residue has been
proposed to form a Ca2+-binding site pocket with aspartate and
glutamate residues of the neighboring subunit [17]. In chick L247T α7
receptors it has been proposed that E172 lines the extracellular
vestibule being part of Ca2+ binding sites that are important in bothion permeation and modulation in those mutated receptors [8]. We
could not pursue the study of the role of E173 on the calcium
regulation of the bovine α7 receptor because all the mutants tested,
including the mutation to glutamine used in previous studies, were
non-functional.
The role of the glutamate in L9 in the modulatory effect of calcium
could be studied in heteromeric receptors where, contrarily to what
happens in α7, the mutation from glutamate to alanine produces
functional receptors. This modulatory effect of calcium has also been
previously observed in muscle and neuronal heteromeric receptors
α3β4 [27]. However, in our hands, the effect is seen only at low
concentrations of ACh, l0 μM or less, where the currents are too small
to obtain reliable data, especially with the double mutant
α3E175Aβ4E175A. Interestingly, this heteromeric receptor, in which
the ﬁve subunits contain the mutation E175A, consistently produced
small (about ten times smaller than the control) but still measurable
currents, as opposite to the similar mutant in α7 receptors, that did
not produce currents at all. Thus, we can conclude that the
requirement for E175 at the end of L9 is different in homomeric and
heteromeric receptors.
Interactions between anionic residues in loops 9 and 10 of
neighboring subunits in muscle have been investigated by a
combination of natural and unnatural mutagenesis and a study of
the change in the values of EC50, but without measuring receptor
expression in the membrane [12]. More recent studies however,
suggest that there is no correlation between the rearrangements in
loop 9 and channel opening in GABA receptors and that it is a
component of the structural machinery that locks ligand into the
agonist-binding site [15].
We consider that, in order to further understand neuronal nAChRs
function, it would be interesting to study in more detail the possible
interactions of the residues in L9 characterized here and the
corresponding ones in the neighboring subunits by combining
techniques that allow the measurement of receptor expression and
function.
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